KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Davita (DVA) Current Deferred Revenue (2009 - 2016)

Davita (DVA) reported Current Deferred Revenue of $277.5 million for Q4 2016, up 81.24% year-over-year from $153.1 million in Q1 2016, and up 81.24% on a QoQ basis from $153.1 million in Q4 2015.

Davita (DVA) has 8 years of Current Deferred Revenue data on file, last reported at $277.5 million in Q4 2016.

  • Quarterly Current Deferred Revenue rose 81.24% year-over-year to $277.5 million in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $277.5 million (up 81.24% YoY) and the FY2016 annual result came in at $277.5 million, up 81.24% from the prior year.
  • Current Deferred Revenue improved to $277.5 million in Q4 2016 per DVA's latest filing, from $153.1 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $277.5 million in Q4 2016 and bottomed at $125.4 million in Q4 2014.
  • The 5-year median for Current Deferred Revenue is $163.5 million (2012), against an average of $177.8 million.
  • The widest annual swing landed in 2014, when Current Deferred Revenue fell 25.99%; it then surged 81.24% in 2016.
  • Tracing DVA's Current Deferred Revenue over 5 years: stood at $163.5 million in 2012, then grew by 3.64% to $169.5 million in 2013, then slipped by 25.99% to $125.4 million in 2014, then grew by 22.06% to $153.1 million in 2015, then jumped by 81.24% to $277.5 million in 2016.
  • Per Business Quant, the three latest DVA Current Deferred Revenue figures stand at $277.5 million (Q4 2016), $153.1 million (Q4 2015), and $125.4 million (Q4 2014).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn
10 Option Care Health 3.27 Bn 3.09 Bn 262.01 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2016 277.48 Mn
Dec 31, 2015 153.10 Mn
Dec 31, 2014 125.44 Mn
Dec 31, 2013 169.48 Mn
Dec 31, 2012 163.52 Mn
Dec 31, 2011 193.97 Mn
Dec 31, 2010 216.66 Mn
Dec 31, 2009 320.19 Mn